Tuberculosis Diagnostic Technology and Market Landscape, Semi-Annual Update

This document is a semi-annual update to the second edition report. The purpose of this document is to highlight developments that have occurred since July 2013 – namely, in the areas of policy development, implementation and scale-up of the Xpert® MTB/RIF assay and efforts to define the characteristics of next-generation molecular tests that could replace smear microscopy. An updated technology pipeline is included for reference; however, a detailed report on newer technologies, including technologies other than nucleic acid amplification tests (NAATs), will be published in 2014 (third edition).